INSIGHTS ON CLINICAL TRIAL DESIGN

• Meeting Regulatory And Patient Needs By Improving Clinical Trial Access

  Learn how to mitigate regulatory risk and improve trial diversity by reducing site burden and leveraging integrated technology to reach U.S. patients in their own communities.

• Can Your Trial Payment Approach Stand Up To Regulatory Scrutiny?

  Fragmented trial payment systems create compliance, ethical, and operational risks. Aligning payments with regulations and ethics improves transparency, reduces burden, and supports audits and participation.

• Integrating Clinical Operations And Pharmacovigilance for Safer Trials

  Learn how integrated planning strengthens decision-making, reduces downstream risk, and supports patient safety while protecting timelines in high-risk studies.

• Applying AI to Study Simulation: From Design to Analysis

  See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.

• Why Tax Reporting Matters In Clinical Trial Participant Payments

  3/20/2026

  Clinical trial participant payments can trigger often overlooked tax reporting obligations. Learn why early visibility into payments matters and how better tracking helps avoid compliance surprises.

• How Expert Medical Information Support Strengthened A Rare Respiratory Therapy Launch

  5/26/2026

  Embedded medical information expertise enabled compliant, real‑time scientific engagement with healthcare professionals at a high‑profile congress during a critical product launch.

• Early Planning Makes Clinical Research Meetings More Effective

  3/20/2026

  Starting earlier can dramatically improve clinical research meetings. Explore how timing affects your choices and why identifying non-negotiables first helps teams manage meeting budgets.

• Rethinking Patient Representation In Breast Cancer Trials For Better Outcomes

  5/22/2026

  Broad patient representation in breast cancer trials is critical, and inclusive trial design improves data relevance, accelerates enrollment, and supports global approval and access.

• Can Patient Liaison Services Transform Clinical Research Access?

  9/25/2025

  Patients often face invisible hurdles in research. Watch how Patient Liaison services can change the journey for participants, sites, and sponsors, making trials easier to join and stay in.